Private company

Vivo Opportunity Fund Holdings, L.P.

Fund registered in the United States, based in Palo Alto, active since 2021. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersPalo Alto, United States²
Legal formFUND²
Kind of organizationFund²
LEI254900UP2Q1RWSQGK886²
StatusActive²
LEI statusIssued and current²
Registered addressC/O The Corporation Trust Company, 19801 Wilmington, United States²
Registered withSecurities and Exchange Commission, 0001930214²

See how the biggest companies compare on our leaderboards

Corporate structure

Vivo Opportunity Fund Holdings, L.P. sits at the top of its group. 27 entities, 5 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Vivo Opportunity Fund Holdings, L.P. Palo Alto, California, United States
- ACHIEVE LIFE SCIENCES, INC. Stake · Bothell, Washington, United States
- Aclaris Therapeutics, Inc. Stake · Wayne, Pennsylvania, United States
- AN2 Therapeutics, Inc. Stake · Menlo Park, California
- ArriVent BioPharma, Inc. Stake · Newtown Square, Pennsylvania
- Avalanche Biotechnologies Stake · Redwood City
- BRIGHT MINDS BIOSCIENCES INC. Stake · Chicago, Illinois
- Camp4 Therapeutics Corp Stake · Watertown, Massachusetts
- Cidara Therapeutics Stake · San Diego, California, United States
- Clene Inc. Stake · Salt Lake City, Utah
- Compass Pathways Stake · Altrincham, United Kingdom
- Compass Therapeutics, Inc. Stake · Boston, Massachusetts
- DBV Technologies Stake · Chatillon, France
- Delcath Systems, Inc. Stake · New York, New York, United States
- Entera Bio Ltd. Stake · L3
- Gracell Biotechnologies Inc. Stake · Shanghai, China
- IMMUNIC, INC. Stake · Wilmington, Delaware, United States
- InMed Pharmaceuticals Inc. Stake · Vancouver, British Columbia, Canada
- Minerva Neurosciences (United States) Stake · Waltham
- Pasithea Therapeutics Corp. Stake · Miami Beach, Florida
- Regulus Therapeutics Inc. Stake · San Diego, California
- Rezolute, Inc. Stake · Redwood City, California, United States
- SAB Biotherapeutics, Inc. Stake · Miami Beach, Florida
- SOLENO THERAPEUTICS INC Stake · Redwood City, California, United States
- TENAX THERAPEUTICS, INC. Stake · Morrisville, North Carolina, United States
- Terns Pharmaceuticals, Inc. Stake · Foster City, California, United States
- and 1 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (26 companies). Each entity in the chart links to its source.

Timeline

Oct 18, 2021Founded Vivo Opportunity Fund Holdings, L.P. is founded²

Stakes it holds

Vivo Opportunity Fund Holdings, L.P. has told the SEC it owns more than 5% of 26 companies, latest first (Schedules 13D and 13G).

ArriVent BioPharma, Inc.SCHEDULE 13G Oct 13, 2026³
Clene Inc.SCHEDULE 13G/A Jun 28, 2023 to Aug 14, 2026⁴
Compass Therapeutics, Inc.SCHEDULE 13G/A Nov 14, 2025 to Aug 14, 2026⁵
Pasithea Therapeutics Corp.SCHEDULE 13G/A Dec 5, 2025 to Aug 14, 2026⁶
SAB Biotherapeutics, Inc.SCHEDULE 13G/A Oct 3, 2025 to Aug 14, 2026⁷
TENAX THERAPEUTICS, INC.SCHEDULE 13G/A Aug 14, 2024 to Aug 14, 2026⁸
Unicycive Therapeutics, Inc.SCHEDULE 13G/A Jul 14, 2023 to Aug 14, 2026⁹
Entera Bio Ltd.SCHEDULE 13G Aug 4, 2026¹⁰
ACHIEVE LIFE SCIENCES, INC.SCHEDULE 13G Jul 8, 2026¹¹
InMed Pharmaceuticals Inc.SCHEDULE 13D Jun 10, 2026¹²
Aclaris Therapeutics, Inc.SCHEDULE 13G/A Nov 21, 2024 to May 12, 2026¹³
BRIGHT MINDS BIOSCIENCES INC.SCHEDULE 13G/A Nov 14, 2025 to May 12, 2026¹⁴
DBV TechnologiesSCHEDULE 13G/A Apr 8, 2025 to May 12, 2026¹⁵
AN2 Therapeutics, Inc.SCHEDULE 13G Mar 13, 2026¹⁶
IMMUNIC, INC.SCHEDULE 13G Feb 20, 2026¹⁷
Camp4 Therapeutics CorpSCHEDULE 13G/A Sep 17, 2025 to Feb 13, 2026¹⁸
Cidara TherapeuticsSCHEDULE 13G/A Dec 9, 2024 to Feb 13, 2026¹⁹
Terns Pharmaceuticals, Inc.SCHEDULE 13G/A Feb 13, 2026²⁰
Minerva Neurosciences (United States)SCHEDULE 13G Dec 31, 2025²¹
Compass PathwaysSCHEDULE 13G/A Aug 25, 2023 to Nov 14, 2025²²
SOLENO THERAPEUTICS INCSCHEDULE 13G/A May 15, 2023 to Nov 14, 2025²³
Delcath Systems, Inc.SCHEDULE 13G/A Jun 22, 2023 to May 15, 2025²⁴
Regulus Therapeutics Inc.SCHEDULE 13G/A Mar 20, 2024 to May 15, 2025²⁵
Avalanche BiotechnologiesSC 13G/A Feb 14, 2024 to Nov 14, 2024²⁶
Rezolute, Inc.SC 13G/A Oct 13, 2023 to Nov 14, 2024²⁷
Gracell Biotechnologies Inc.SC 13G/A Aug 18, 2023 to Feb 13, 2024²⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVivo Opportunity Fund Holdings, L.P. filings on SEC EDGAR
2
GLEIFVivo Opportunity Fund Holdings, L.P. LEI record (254900UP2Q1RWSQGK886)
3
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G on ArriVent BioPharma, Inc.
4
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on Clene Inc.
5
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on Compass Therapeutics, Inc.
6
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on Pasithea Therapeutics Corp.
7
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on SAB Biotherapeutics, Inc.
8
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on TENAX THERAPEUTICS, INC.
9
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on Unicycive Therapeutics, Inc.
10
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G on Entera Bio Ltd.
11
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G on ACHIEVE LIFE SCIENCES, INC.
12
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13D on InMed Pharmaceuticals Inc.
13
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on Aclaris Therapeutics, Inc.
14
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on BRIGHT MINDS BIOSCIENCES INC.
15
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on DBV Technologies
16
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G on AN2 Therapeutics, Inc.
17
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G on IMMUNIC, INC.
18
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on Camp4 Therapeutics Corp
19
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on Cidara Therapeutics
20
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on Terns Pharmaceuticals, Inc.
21
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G on Minerva Neurosciences (United States)
22
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on Compass Pathways
23
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on SOLENO THERAPEUTICS INC
24
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on Delcath Systems, Inc.
25
SEC EDGARVivo Opportunity Fund Holdings, L.P. SCHEDULE 13G/A on Regulus Therapeutics Inc.
26
SEC EDGARVivo Opportunity Fund Holdings, L.P. SC 13G/A on Avalanche Biotechnologies
27
SEC EDGARVivo Opportunity Fund Holdings, L.P. SC 13G/A on Rezolute, Inc.
28
SEC EDGARVivo Opportunity Fund Holdings, L.P. SC 13G/A on Gracell Biotechnologies Inc.